Germany Building Center for Cancer, Neurodegenerative Protein Biomarker Research | GenomeWeb

This story originally ran on Dec. 23.

By Tony Fong

The government of Germany has committed at least €37 million [$53 million] to create what is expected to be Europe's largest center devoted to developing new protein biomarkers for cancer and Alzheimer's and Parkinson's diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.